Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

By Day Douglas G.   Hollander David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1435-1442

Informa Healthcare

Access to resources Recommend Favorite

Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma

By Holló Gábor   Kóthy Péter  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1755-1761

Informa Healthcare

Access to resources Recommend Favorite

Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database

By Lazaridou Marie-Noëlle   Montgomery Donald M. I.   Ho Whye Onn   Jaberoo David  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2725-2728

Informa Healthcare

Access to resources Recommend Favorite

Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost

By Covert David   Robin Alan L.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 971-976

Informa Healthcare

Access to resources Recommend Favorite

Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety

By Martinez-de-la-Casa J.M.   Castillo A.   Garcia-Feijoo J.   Mendez-Hernandez C.   Fernandez-Vidal A.   Garcia-Sanchez J.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1333-1339

Informa Healthcare

Access to resources Recommend Favorite